Philipp von Loeper to be New Chairman of the Supervisory Board of Eppendorf AG
News Jun 08, 2016
At the Annual General Meeting of June 3, 2016, Klaus Fink stepped down from his position as Chairman of the Supervisory Board of Eppendorf AG and resigned from the Board. Mr. Fink led and developed the company as Chief Executive Officer for 22 years before becoming Chairman of the Supervisory Board in 2011.
The Supervisory Board, the Management Board and both owner families regret this decision and extend their sincere thanks to Mr. Fink for his outstanding work and his great commitment during all these years.
Philipp von Loeper has been elected the new Chairman of the Supervisory Board. Mr. von Loeper has been a member of the Supervisory Board since 2011 in the capacity of Vice Chairman, and was previously active on the company’s Compensation Committee.
Hans Hinz was elected Vice Chairman of the Supervisory Board.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.